Glycemic traits

Biomarker

1 paper3 findings

  • Humans1

Effects

1

Type 2 diabetes

mediatesin humans1

1 study
  1. Glycemic traits mediate type 2 diabetes in humans (19–32% of the KDMAccel burden–T2D effect; 16–24% of the PhenoAgeAccel burden–T2D effect).

    “Mediation analyses revealed that these glycemic traits on average mediated 19~32% of the KDMAccel burden-T2D effect and 16~24% of the PhenoAgeAccel burden-T2D effect.”

    HumansMediation analysis of associations between biological age acceleration burdens and incident T2Dn = 13,751

    Longitudinal insights into dynamic patterns and cumulative burdens of biological age acceleration in relation to type II diabetes mellitus, all-cause mortality and glycemic traits

    medRxiv7 Apr 2026Preprint

More on Type 2 diabetes

Associations

1

DunedinPACE

upin humans1

1 study
  1. Glycemic traits predict DunedinPACE in humans.

    “Cross-lagged models revealed that glycemic traits (fasting plasma glucose, HbA1c, and TyG index) preceded DunedinPACE increases”

    HumansCross-lagged analysis in twins; glycemic traits comprised fasting plasma glucose, HbA1c, and TyG indexMean of 4.6 yearsn = 314

    Association between epigenetic age and type 2 diabetes mellitus or glycemic traits: A longitudinal twin study

    Aging cell25 Apr 2024

  2. DunedinPACE is associated with glycemic traits in humans.

    “In the cross-sectional analysis, positive associations were identified between DunedinPACE and glycemic traits”

    HumansCross-sectional analysis in twinsn = 1,070

    Association between epigenetic age and type 2 diabetes mellitus or glycemic traits: A longitudinal twin study

    Aging cell25 Apr 2024

More on DunedinPACE

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 1May 2026: 0Jun 2026: 3Jul 2026: 1Aug 2026: 1Sep 2026: 2Oct 2026: 08 in 12 months
Neurology Genetics

GLP-1 receptor agonists link to lower stroke and Alzheimer risk

A cross-ancestry Mendelian randomization study of up to 1,812,017 individuals linked genetically proxied GLP-1 receptor agonist exposure to reduced risk of stroke and…A cross-ancestry Mendelian randomization study of up to 1,812,017 individuals linked genetically proxied GLP-1 receptor agonist exposure to reduced risk of stroke and Alzheimer disease.

Mendelian randomisation in peopleGLP-1 receptor agonists